Regavirumab
Modify Date: 2024-01-13 12:29:58
Regavirumab structure
|
Common Name | Regavirumab | ||
|---|---|---|---|---|
| CAS Number | 153101-26-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RegavirumabRegavirumab (MCA C23) is a human monoclonal antibody against cytomegalovirus (CMV), human serum albumin (HSA) and amino acetic acid[1]. |
| Name | Regavirumab |
|---|
| Description | Regavirumab (MCA C23) is a human monoclonal antibody against cytomegalovirus (CMV), human serum albumin (HSA) and amino acetic acid[1]. |
|---|---|
| Related Catalog | |
| In Vivo | 注射 Regavirumab 后获得的大鼠血清显示出强大的抑制斑块形成的活性[1]。 Regavirumab (2 mg/kg/周，5次)，第4次注射后24 h, Regavirumab 血药浓度达到稳定状态 (74.4±11.8 μg/mL)。末次注射后的消除半衰期与单次注射后相似[1]。 |
| References |
| No Any Chemical & Physical Properties |